Barclays
ABVX

Barclays’s Abivax ABVX Stock Holding History

Barclays’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.1M Sell
90,775
-218,014
-71% -$25.8M ﹤0.01% 1447
2025
Q4 		$41.6M Buy
308,789
+232,447
+304% +$25.4M 0.01% 872
2025
Q3 		$6.48M Sell
76,342
-37,049
-33% -$2.27M ﹤0.01% 2002
2025
Q2 		$867K Buy
113,391
+111,913
+7,572% +$729K ﹤0.01% 3436
2025
Q1 		$9.24K Buy
1,478
+383
+35% +$2.59K ﹤0.01% 4877
2024
Q4 		$8.02K Buy
+1,095
New +$10.1K ﹤0.01% 5019

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return